Trading Analysis Report: SMR
- Analysis date: 2026-05-31
- Processed decision: Speculative Hold
- Price Target: 15
I. Analyst Team Reports
Market Analyst
Market Report
NuScale Power (SMR) closed at $12.67 on May 29, 2026, up from the prior close but still far below its $57.42 52-week high. The stock is above its $11.47 50-day average but below its $22.43 200-day average.
The market setup is volatile. yfinance showed beta of 2.252, average volume of about 29.52 million shares, latest volume of about 44.19 million, and a one-year return of about negative 60.4%.
NuScale has strategic optionality around nuclear power demand, but current revenue is tiny. The 10-Q showed Q1 2026 revenue of only $0.565 million and yfinance showed price/sales of about 234.89x.
Market read: the stock has rebound potential from depressed levels, but commercial execution risk remains high. Assign Speculative Hold with a $15 target.
Sentiment Analyst
Sentiment Report
Sentiment toward SMR is mixed. Nuclear power has become a high-interest theme because of data-center load growth, grid reliability, decarbonization, and energy security.
NuScale has clear narrative strength. The company says it is the first and only SMR to have its designs certified by the U.S. Nuclear Regulatory Commission, and its 77 MWe NuScale Power Module can be configured up to 924 MWe with 12 modules.
The Q1 update also reinforced project optionality. ENTRA1 continued work with TVA for planning up to 6 gigawatts of NuScale SMR capacity, and SN Nuclearelectrica shareholders approved proceeding with the next RoPower phase for 6 NuScale Power Modules in Romania.
The bearish sentiment comes from commercialization timing, dilution, and losses. SMR is still far below its 52-week high, and the 10-Q showed net loss of $46.685 million in Q1 2026.
Sentiment read: the story is strong, but the financial model is still early. Speculative Hold is appropriate.
News Analyst
News Report
The key current sources are NuScale's May 7, 2026 Q1 results release and the March 31, 2026 Form 10-Q.
NuScale ended Q1 2026 with $1.0 billion in liquidity and capital resources. The 10-Q broke that down as $341.1 million of cash and cash equivalents plus $549.0 million of short-term investments, with no debt.
Project news was constructive. ENTRA1 continued TVA planning for up to 6 GW of SMR capacity, RoPower advanced toward a 6-module project in Romania, and NuScale expanded its Framatome supply chain partnership.
Financial results were weak. Q1 revenue fell to $0.565 million from $13.375 million because prior-year RoPower license and Fluor FEED Phase 2 activity had no comparable 2026 activity. Q1 net loss was $46.685 million.
News read: liquidity and strategic progress are positives, but revenue conversion remains the central question.
Fundamentals Analyst
Fundamentals Report
NuScale's fundamentals are dominated by liquidity, commercialization milestones, dilution, and project execution rather than current earnings.
Liquidity is strong. The 10-Q showed $341.1 million of cash, $549.0 million of short-term investments, and no debt at March 31, 2026. NuScale also said cash and investments should satisfy requirements for the next 12 months and beyond.
The income statement remains early-stage. Q1 2026 revenue was $0.565 million, gross margin was $0.021 million, R&D expense was $12.805 million, G&A expense was $24.839 million, and loss from operations was $57.524 million.
Cash use and dilution are material. Q1 operating cash use was $314.678 million, including a $259.9 million ENTRA1 payment. NuScale sold shares under its ATM in Q1 and sold another 22.360004 million Class A shares after quarter-end for $213.528 million net proceeds.
Fundamental read: the balance sheet buys time, but valuation depends on contracts becoming deployable revenue.
II. Research Team Decision
Bull Researcher
Bull Research
The bull case is that NuScale is one of the most visible listed pure plays on small modular nuclear reactors.
The company has a differentiated regulatory position. NuScale says it is the first and only SMR technology provider with a U.S. NRC-approved design, and its module can address electricity generation, data centers, district heating, desalination, hydrogen, and process heat markets.
The project pipeline has credible anchors. TVA/ENTRA1 planning covers up to 6 GW of NuScale SMR capacity, while the RoPower project in Romania advanced to the next phase for 6 NuScale Power Modules.
The balance sheet is also supportive. Liquidity was about $1.0 billion at quarter-end before additional post-quarter ATM proceeds.
Bull conclusion: if NuScale converts partnerships into binding commercial deployments, the current price can recover.
Bear Researcher
Bear Research
The bear case is that NuScale remains a high-cost commercialization story with minimal current revenue.
Q1 2026 revenue was only $0.565 million, down from $13.375 million a year earlier. The 10-Q showed operating loss of $57.524 million and net loss of $46.685 million.
Dilution is a real cost of the strategy. The company issued shares in Q1, had about $962.1 million still available under the 2026 ATM program at quarter-end, and sold another 22.36 million shares after quarter-end.
Legal and execution risks also matter. The 10-Q discussed shareholder litigation related to ENTRA1 statements and noted that the market for SMRs is still developing.
Bear conclusion: SMR is not cheap on current fundamentals, and the stock can stay volatile until binding deployments and revenue scale are visible.
Research Manager
Research Manager Synthesis
The bull case is strategic: NuScale has NRC-certified SMR technology, large-market nuclear demand, strong liquidity, and project optionality with TVA/ENTRA1 and RoPower.
The bear case is financial: current revenue is tiny, losses are large, cash use is high, and dilution is ongoing.
The correct conclusion is Speculative Hold. The stock has upside from current depressed levels, but the evidence does not support a full Buy rating before revenue conversion improves.
Synthesis: assign Speculative Hold with a $15 target.
III. Trading Team Plan
Trader
Trader View
SMR is trying to stabilize after a large decline. The close of $12.67 is above the 50-day average but still below the 200-day average and far below the $57.42 52-week high.
The upside trigger is confirmation of binding commercial progress with TVA/ENTRA1, RoPower, or other large customers. The downside trigger is dilution, project delay, weak revenue, or renewed litigation concern.
Near-term trading references are the 50-day average near $11.47, the 200-day average near $22.43, and the yfinance mean analyst target near $15.36.
Trading plan: hold risk-sized exposure; add only if commercial milestones become more concrete.
IV. Risk Management Team Decision
Aggressive Analyst
Aggressive Risk View
Aggressive investors may hold SMR because nuclear sentiment and data-center power demand can support high optionality.
The liquidity position gives NuScale time to develop commercial deployments, supply chain readiness, and customer contracts. The company ended Q1 with about $1.0 billion of liquidity and capital resources.
The risk is that the story remains ahead of the numbers. Q1 revenue was $0.565 million, operating loss was $57.524 million, and dilution continues.
Aggressive conclusion: hold only with acceptance that the investment is milestone-driven.
Conservative Analyst
Conservative Risk View
Conservative investors should be careful with SMR. It is not a mature utility or profitable industrial company.
The company has no debt and strong liquidity, but it also had Q1 net loss of $46.685 million, Q1 operating cash use of $314.678 million, and ongoing share issuance.
The valuation still embeds future success. yfinance showed market cap of about $4.39 billion and price/sales of about 234.89x despite very low revenue.
Conservative conclusion: wait for binding contracts and revenue scale before increasing exposure.
Neutral Analyst
Neutral Risk View
The neutral view is that NuScale is a high-quality nuclear option with a long commercialization runway.
The strongest positives are NRC design certification, cash and investments, and visible project discussions. The strongest negatives are low revenue, losses, dilution, legal risk, and dependence on third-party project execution.
The $15 target is modestly above current price and below the yfinance mean target of $15.36, reflecting upside without assuming a full commercial breakout.
Neutral conclusion: Speculative Hold is the cleanest rating.
V. Portfolio Manager Decision
Portfolio Manager
Portfolio Manager Decision
Rating: Speculative Hold Price Target: 15
Horizon: 6-12 months Current Price Reference: $12.67 close on 2026-05-29
NuScale Power is a nuclear SMR commercialization story, not a near-term earnings story. The company says its technology is NRC-certified, and Q1 updates highlighted TVA/ENTRA1 planning for up to 6 GW of capacity, RoPower progress for 6 NuScale Power Modules in Romania, and an expanded Framatome supply chain relationship.
The balance sheet is a real positive. NuScale ended Q1 2026 with about $1.0 billion of liquidity and capital resources, including $341.1 million of cash and $549.0 million of short-term investments, with no debt.
The problem is that revenue has not arrived at scale. Q1 2026 revenue was $0.565 million, net loss was $46.685 million, and operating cash use was $314.678 million, partly because of a $259.9 million ENTRA1 payment. The company also sold shares in Q1 and again after quarter-end, increasing dilution risk.
The $15 target gives moderate upside from $12.67 and is close to, but slightly below, yfinance's $15.36 mean analyst target. Existing speculative holders can maintain exposure, but new buying should wait for clearer binding contract and revenue evidence.